Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,997 | -16,993 | -9,279 | -3,263 | -15,752 |
| Depreciation Amortization | 864 | 698 | 531 | 282 | 1,038 |
| Accounts receivable | 121 | -272 | -333 | -60 | -107 |
| Other Working Capital | 1,705 | 1,767 | -123 | -295 | -14,020 |
| Other Operating Activity | 740 | -97 | -1,169 | -1,608 | 10,738 |
| Operating Cash Flow | $-19,567 | $-14,897 | $-10,373 | $-4,944 | $-18,103 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -47,563 | -15,365 | -15,300 | N/A | 10,745 |
| PPE Investments | -279 | -251 | -205 | -83 | -551 |
| Investing Cash Flow | $-47,842 | $-15,616 | $-15,505 | $-83 | $10,194 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 23,964 | 23,916 | 82 | 44 | 278 |
| Financing Cash Flow | $23,964 | $23,916 | $82 | $44 | $278 |
| Exchange Rate Effect | 1,889 | 2,081 | 2,355 | 2,396 | -5,744 |
| Beginning Cash Position | 58,651 | 58,651 | 58,651 | 58,651 | 72,026 |
| End Cash Position | 17,095 | 54,135 | 35,210 | 56,064 | 58,651 |
| Net Cash Flow | $-41,556 | $-4,516 | $-23,441 | $-2,587 | $-13,375 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,567 | -14,897 | -10,373 | -4,944 | -18,103 |
| Capital Expenditure | -279 | -251 | -205 | -83 | -551 |
| Free Cash Flow | -19,846 | -15,148 | -10,578 | -5,027 | -18,654 |